Differential effects of cariprazine, LY379268 and donepezil on EEG oscillations and auditory steady-state response in MK-801-treated rats: relevance for schizophrenia drug development
- 14 March 2026
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 292, 110929
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Xanomeline/Trospium Chloride: First ApprovalDrugs, 2024
- Efficacy of Cariprazine in the Psychosis Spectrum: A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials in Schizophrenia and Bipolar DisorderCNS Drugs, 2024
- Efficacy and Safety of Xanomeline-Trospium Chloride in SchizophreniaJAMA Psychiatry, 2024
- Effects of M1 and M4 activation on excitatory synaptic transmission in CA1Hippocampus, 2017
- Spontaneous Gamma Activity in SchizophreniaJAMA Psychiatry, 2015
- Cariprazine, a dopamine D3-receptor-preferring partial agonist, blocks phencyclidine-induced impairments of working memory, attention set-shifting, and recognition memory in the mousePsychopharmacology, 2012
- Validation and pharmacological characterisation of MK-801-induced locomotor hyperactivity in BALB/C mice as an assay for detection of novel antipsychoticsPsychopharmacology, 2010
- Unique pharmacological profile of aripiprazole as the phasic component busterPsychopharmacology, 2007
- Stimulation of D2 receptors in the prefrontal cortex reduces PCP-induced hyperactivity, acetylcholine release and dopamine metabolism in the nucleus accumbensJournal of Neural Transmission, 2006
- MK‐801 inhibition of nicotinic acetylcholine receptor channelsSynapse, 1991